© 2022 MJH Life Sciences™ and Neurology Live. All rights reserved.
American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting
Cell Therapies Offer Hope But Are Often Misused
October 13, 2018
Cellular therapies have the potential to make a meaningful difference for patients with neurological disorders, if used correctly.
IncobotulinumtoxinA Reduces Sialorrhea Across Neurological Disorders
October 12, 2018
IncobotulinumtoxinA significantly reduced unstimulated salivary flow rate for patients with sialorrhea.
Patisiran Shows Sustained Improvements in Disease Progression for hATTR Amyloidosis
October 12, 2018
Patisiran maintained improvements in mNIS+7 and rapidly halted neurologic disease progression in hATTR amyloidosis.
Subcutaneous Immunoglobulin Effective Alternative to Intravenous for Myasthenia Gravis
October 11, 2018
Subcutaneous immunoglobulin is an effective and well-tolerated alternative to intravenous immunoglobulin for myasthenia gravis.
Eculizumab's Myasthenia Gravis Benefits Sustained in Long-Term Extension Study
October 11, 2018
Eculizumab showed sustained activity and tolerability through 3 years for generalized myasthenia gravis.